NewslettersProstate Cell News Targeting Myeloid Chemotaxis to Reverse Prostate Cancer Therapy Resistance By Bob - October 19, 2023 0 Investigators showed that inhibition of myeloid chemotaxis could reduce tumor-elicited myeloid inflammation and reverse therapy resistance in a subset of metastatic CRPC patients. [Nature] AbstractPress Release